Results 71 to 80 of about 10,090 (144)

Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. [PDF]

Nat Commun
Català-Moll F, Blázquez-Bondia C, Farré-Badia J, Torres F, Manzardo C, Bonfill E, Curran A, Domingo P, Podzamczer D, Force L, Falcó V, Parera M, Casadellà M, Miró JM, Noguera-Julian M, Paredes R, ADVANZ-4 MISTRAL investigators.   +16 more
europepmc   +1 more source

A cross-sectional study of viral load suppression among youth living with HIV in Namibia. [PDF]

South Afr J HIV Med
Kamangu JWN, Mboweni SH.
europepmc   +1 more source

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens. [PDF]

J Antimicrob Chemother
Dickinson L, Else L, Venter WDF, Boffito M, Brand R, Waitt C, Hill A, Khoo S.   +7 more
europepmc   +1 more source

HIV low-level viraemia: considerations for prevention and treatment in an era of highly effective and durable antiretroviral therapy regimens. [PDF]

J Int AIDS Soc
Vojnov L, Bekker LG, Cohen MS, Jahn A, Havlir D, Boeras D, Ford N, Kumarasamy N, Broyles LN.   +8 more
europepmc   +1 more source

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence. [PDF]

Clin Infect Dis
Nutt CT, Lessells RJ, Muyindike WR, Johnson LS, Kouyos RD, Loosli T, Ombajo LA, Brijkumar J, Hyle EP, Moosa MS, Gandhi M, Vitoria MAA, Jordan MR, Siedner MJ, McCluskey SM.   +14 more
europepmc   +1 more source

Reduced Metformin Concentrations in Obese Women With Human Immunodeficiency Virus Treated With Dolutegravir. [PDF]

J Infect Dis
van Rensburg R, Kellermann T, Pillay-Fuentes Lorente V, du Plessis C, Orrell C, Maposa I, Schreuder C, Jennings L, van Zyl G, Schifitto G, Decloedt E.   +10 more
europepmc   +1 more source

Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV. [PDF]

J Health Econ Outcomes Res
Chastek B, Mordi U, Christoph MJ, Le LB, Lim T, Majethia S, Trom C, Cohen J.   +7 more
europepmc   +1 more source

Prevalence and factors associated with hyperglycemia among children living with HIV on dolutegravir in Kabale district, southwestern Uganda. [PDF]

PLoS One
Idow LH, Nduhukire T, Ankunda S, Tumwesigire S, Nyeko F, Tumwine JK.   +5 more
europepmc   +1 more source

Alternative Administration of Antiretroviral Therapy in People with HIV Unable to Swallow: A Scoping Review. [PDF]

HIV AIDS (Auckl)
Abdessamad H, Baroody C, Pogorzelski K, Jamaleddine W, Kitonga MS, Omar H, Amankrah SA, Allen-Brown K, Dandachi D.   +8 more
europepmc   +1 more source

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol. [PDF]

PLoS One
Ombajo LA, Nkuranga J, Penner J, Kamau EW, Ismael N, Munseri P, Ayakaka I, Labhardt N, Wamalwa D, Ramgi P, Chissumba RM, Wagude J, Bakari M, Omodi V, Otieno E, Abuogi L, Patel R, Opondo C, Grint D, King'wara L, Macharia A, Mulwa A, Amoth P, Ndovu study group.   +23 more
europepmc   +1 more source